Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/210000
Title: Deletion of Gadd45a Expression in Mice Leads to Cognitive and Synaptic Impairment Associated with Alzheimer’s Disease Hallmarks.
Author: Griñán Ferré, Christian
Jarné-Ferrer, Júlia
Bellver-Sanchis, Aina
Ribalta Vilella, Marta
Barroso Fernández, Emma
Salvador, Jesús M.
Jurado Aguilar, Javier
Palomer Tarridas, Francesc Xavier
Vázquez Carrera, Manuel
Pallàs i Llibería, Mercè, 1964-
Keywords: Malaltia d'Alzheimer
Malalties neurodegeneratives
Epigenètica
Alzheimer's disease
Neurodegenerative Diseases
Epigenetics
Issue Date: 23-Feb-2024
Publisher: MDPI
Abstract: <p><em>Gadd45 genes have been implicated in survival mechanisms, including apoptosis, autophagy,</em></p><p><em>cell cycle arrest, and DNA repair, which are processes related to aging and life span. Here, we</em></p><p><em>analyzed if the deletion of Gadd45a activates pathways involved in neurodegenerative disorders such</em></p><p><em>as Alzheimer’s Disease (AD). This study used wild-type (WT) and Gadd45a knockout (Gadd45a−/−)</em></p><p><em>mice to evaluate AD progression. Behavioral tests showed that Gadd45a−/− mice presented lower</em></p><p><em>working and spatial memory, pointing out an apparent cognitive impairment compared with WT</em></p><p><em>animals, accompanied by an increase in Tau hyperphosphorylation and the levels of kinases involved</em></p><p><em>in its phosphorylation in the hippocampus. Moreover, Gadd45a−/− animals significantly increased the</em></p><p><em>brain’s pro-inflammatory cytokines and modified autophagy markers. Notably, neurotrophins and</em></p><p><em>the dendritic spine length of the neurons were reduced in Gadd45a−/− mice, which could contribute</em></p><p><em>to the cognitive alterations observed in these animals. Overall, these findings demonstrate that the</em></p><p><em>lack of the Gadd45a gene activates several pathways that exacerbate AD pathology, suggesting that</em></p><p><em>promoting this protein’s expression or function might be a promising therapeutic strategy to slow</em></p><p><em>down AD progression.</em></p>
Note: Reproducció del document publicat a:
It is part of: International Journal of Molecular Sciences, 2024
URI: http://hdl.handle.net/2445/210000
ISSN: 1661-6596
Appears in Collections:Articles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica)

Files in This Item:
File Description SizeFormat 
858356.pdf3.86 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons